Literature DB >> 20711230

Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex.

Xianmiao Wang1, Ying Li, Aiping Mao, Chao Li, Yongkui Li, Po Tien.   

Abstract

Viral RNAs produced during viral infection are recognized by the cytoplasmic RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5). A central adapter protein downstream of RIG-I and MDA5 is the mitochondrial membrane protein virus-induced signaling adaptor (VISA), which mediates the induction of type I interferons (IFNs) through the activation of transcription factors such as nuclear factor-kappaB (NF-kappaB) and IFN-regulatory factor-3 (IRF3). Here we found that hepatitis B virus (HBV)-encoded X protein (HBx) acts as an inhibitor of virus-triggered IRF3 activation and IFN-beta induction. Reporter and plaque assays indicate that HBx inhibits signaling by components upstream but not downstream of VISA. Immunoprecipitation experiments indicate that HBx interacts with VISA and disrupts the association of VISA with its upstream and downstream components. These findings suggest that HBx acts as a suppressor of virus-triggered induction of type I IFNs, which explains the observation that HBV causes transient and chronic infection in hepatocytes but fails to activate the pattern recognition receptor-mediated IFN induction pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711230      PMCID: PMC4002683          DOI: 10.1038/cmi.2010.36

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  37 in total

1.  Type I IFN modulates innate and specific antiviral immunity.

Authors:  J E Durbin; A Fernandez-Sesma; C K Lee; T D Rao; A B Frey; T M Moran; S Vukmanovic; A García-Sastre; D E Levy
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

Review 2.  Hepatitis B virus X protein: a multifunctional viral regulator.

Authors:  S Murakami
Journal:  J Gastroenterol       Date:  2001-10       Impact factor: 7.527

3.  RIGging an antiviral defense--it's in the CARDs.

Authors:  David E Levy; Isabelle J Marié
Journal:  Nat Immunol       Date:  2004-07       Impact factor: 25.606

Review 4.  Insights into host responses against pathogens from transcriptional profiling.

Authors:  Richard G Jenner; Richard A Young
Journal:  Nat Rev Microbiol       Date:  2005-04       Impact factor: 60.633

5.  Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication.

Authors:  M Melegari; P P Scaglioni; J R Wands
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication.

Authors:  Hong Tang; Luvsanjav Delgermaa; Feijun Huang; Naoki Oishi; Li Liu; Fang He; Liansan Zhao; Seishi Murakami
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Posttranscriptional regulation of hepatitis B virus replication by the precore protein.

Authors:  P P Scaglioni; M Melegari; J R Wands
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.

Authors:  Jun Wu; Zhongji Meng; Min Jiang; Rongjuan Pei; Martin Trippler; Ruth Broering; Agnes Bucchi; Jan-Peter Sowa; Ulf Dittmer; Dongliang Yang; Michael Roggendorf; Guido Gerken; Mengji Lu; Joerg F Schlaak
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

9.  Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.

Authors:  Julianne Stack; Ismar R Haga; Martina Schröder; Nathan W Bartlett; Geraldine Maloney; Patrick C Reading; Katherine A Fitzgerald; Geoffrey L Smith; Andrew G Bowie
Journal:  J Exp Med       Date:  2005-03-14       Impact factor: 14.307

10.  The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense.

Authors:  Mary T Harte; Ismar R Haga; Geraldine Maloney; Pearl Gray; Patrick C Reading; Nathan W Bartlett; Geoffrey L Smith; Andrew Bowie; Luke A J O'Neill
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  37 in total

1.  N 6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling.

Authors:  Geon-Woo Kim; Hasan Imam; Mohsin Khan; Aleem Siddiqui
Journal:  J Biol Chem       Date:  2020-07-27       Impact factor: 5.157

Review 2.  The role of innate immunity in HBV infection.

Authors:  Qiuju Han; Cai Zhang; Jian Zhang; Zhigang Tian
Journal:  Semin Immunopathol       Date:  2012-07-20       Impact factor: 9.623

3.  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication.

Authors:  Amanda J Hodgson; Joseph M Hyser; Victor V Keasler; Yong Cang; Betty L Slagle
Journal:  Virology       Date:  2012-02-17       Impact factor: 3.616

Review 4.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

5.  A MAVS/TICAM-1-independent interferon-inducing pathway contributes to regulation of hepatitis B virus replication in the mouse hydrodynamic injection model.

Authors:  Chean Ring Leong; Hiroyuki Oshiumi; Masaaki Okamoto; Masahiro Azuma; Hiromi Takaki; Misako Matsumoto; Kazuaki Chayama; Tsukasa Seya
Journal:  J Innate Immun       Date:  2014-08-08       Impact factor: 7.349

Review 6.  Innate and Adaptive Immune Regulation During Chronic Viral Infections.

Authors:  Elina I Zuniga; Monica Macal; Gavin M Lewis; James A Harker
Journal:  Annu Rev Virol       Date:  2015-09-02       Impact factor: 10.431

Review 7.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

8.  MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1.

Authors:  Yongkui Li; Jiajia Xie; Xiupeng Xu; Jun Wang; Fang Ao; Yushun Wan; Ying Zhu
Journal:  Protein Cell       Date:  2012-11-12       Impact factor: 14.870

Review 9.  Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.

Authors:  Yun Zhou; Ying Zhang; Jonathan P Moorman; Zhi Q Yao; Zhan S Jia
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

10.  Porcine Deltacoronavirus Accessory Protein NS6 Antagonizes Interferon Beta Production by Interfering with the Binding of RIG-I/MDA5 to Double-Stranded RNA.

Authors:  Puxian Fang; Liurong Fang; Jie Ren; Yingying Hong; Xiaorong Liu; Yunyang Zhao; Dang Wang; Guiqing Peng; Shaobo Xiao
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.